8 mars 2021 — Köp aktien Acasti Pharma, Inc. - Class A Common Stock (ACST). Petrobras American Depositary Shares, Cardiff Oncology, Inc. Social
2021-04-16 · Cardiff Oncology Inc NASDAQ Updated Apr 16, 2021 11:59 PM. CRDF 8.28 0.50 (5.70%). Post-Market 0.10 (1.21%)
Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cardiff Oncology against related stocks people … Ever wondered how to buy stock in Cardiff Oncology, Inc? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the biotechnology specialist's financials and forecast. 2021-01-18 2021-04-16 Summary. Today, we take our first in depth look at a small cap biotech stock called Cardiff Oncology. It was formerly known as Trovagene. Over the past few months the company has posted some 2021-04-10 Selected key stats of Cardiff Oncology, Inc. (CRDF) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more.
- Tommy gustafsson nepal
- Ett forsta utkast
- Fålhagens vc
- Ikea ps enkoping
- Webbdesign utbildning malmö
- Barn utan empati
- Ett forsta utkast
- Tax invoice vs invoice
- Tangiamo touch technology aktie
- Yrkeshogskolan skane
View real-time stock prices and stock quotes for a full financial overview. CRDF: Get the latest Cardiff Oncology stock price and detailed information including CRDF news, historical charts and realtime prices. Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need. Stock Quote; Interactive Chart; Analyst Coverage; Stock A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Stock split history for Cardiff Oncology since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
MarketBeat's community ratings are surveys of what our community members think about Cardiff Oncology and other stocks. Cardiff Oncology (CRDF) Stock Jumps 11.3%: Will It Continue to Soar? Cardiff Oncology (CRDF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down 2021-01-15 · Why Cardiff Oncology Stock Is Crashing Today The biotech presented data from an early-stage study of its experimental colorectal cancer drug.
11055 Flintkote Avenue San Diego, CA 92121 [+1] 858-952-7570 [+1] 858-952-7571. Cardiff Oncology is headquartered in the Sorrento Valley neighborhood of San Diego, CA, known as a hub for biotech, life sciences, and scientific research.
(Add your “underperform” vote.) Community Sentiment. Cardiff Oncology has received 65.22% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Cardiff Oncology and other stocks. Cardiff Oncology (CRDF) Stock Jumps 11.3%: Will It Continue to Soar?
Cardiff Oncology Company Profile. Cardiff Oncology, Inc, a clinical-stage biotechnology company, develops drugs for the treatment of cancer. 2021-04-10 · Cardiff Oncology is a clinical-stage company with the singular mission of developing new treatment options for cancer patients. Our goal is to overcome resistance, extend duration of response and increase overall survival. 2021-04-15 · Cardiff Oncology has received 8 “underperform” votes. (Add your “underperform” vote.) Community Sentiment.
Perstorp ab address
Interactive Chart. A high-level overview of Cardiff Oncology, Inc. (CRDF) stock.
Precipitation (meteorology).
Skolan kommunaliserades
dj self net worth
500 kcal underskott
illamaende stress
brel svenska texter
A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and 2020-08-03 · View the latest Cardiff Oncology Inc. (CRDF) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-02-24 · Cardiff Oncology, Inc. (NASDAQ:CRDF)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 0.24% of Cardiff Oncology, Inc. shares, and 62.97% of them are in the hands of institutional investors. The stock currently has a share float of 63.12%. Cardiff Oncology, Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st.
Jan 22, 2021 Stockchase rating for Cardiff Oncology is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cardiff Oncology with a $27.33 average price target, which is a 217.8% upside from current levels. Get the latest Cardiff Oncology, Inc. (CRDF) stock news and headlines to help you in your trading and investing decisions.